Nexus Spine’s Patented Tranquil® Interbody Implants Achieve Exceptional Outcomes

DRAPER, Utah, Sept. 11, 2025 /PRNewswire/ — Nexus Spine is excited to share pilot study results of a comparative radiographic assessment of ACDF outcomes in a series of patients who were selected for common risk factors of subsidence, instability, and delayed bone growth. Specifically,…

Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks